Creative Financial Designs Inc. ADV Buys 160 Shares of Waters Corporation $WAT

Creative Financial Designs Inc. ADV raised its stake in shares of Waters Corporation (NYSE:WAT) by 533.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 190 shares of the medical instruments supplier’s stock after buying an additional 160 shares during the period. Creative Financial Designs Inc. ADV’s holdings in Waters were worth $66,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Creekmur Asset Management LLC raised its stake in shares of Waters by 32.5% in the 2nd quarter. Creekmur Asset Management LLC now owns 828 shares of the medical instruments supplier’s stock valued at $289,000 after acquiring an additional 203 shares in the last quarter. Strs Ohio raised its position in shares of Waters by 84.4% in the second quarter. Strs Ohio now owns 5,228 shares of the medical instruments supplier’s stock valued at $1,825,000 after purchasing an additional 2,393 shares during the period. Amalgamated Bank raised its position in shares of Waters by 2.4% in the second quarter. Amalgamated Bank now owns 12,561 shares of the medical instruments supplier’s stock valued at $4,384,000 after purchasing an additional 291 shares during the period. Assetmark Inc. raised its position in shares of Waters by 34.9% in the second quarter. Assetmark Inc. now owns 2,084 shares of the medical instruments supplier’s stock valued at $727,000 after purchasing an additional 539 shares during the period. Finally, New York Life Investment Management LLC raised its position in shares of Waters by 0.7% in the second quarter. New York Life Investment Management LLC now owns 8,916 shares of the medical instruments supplier’s stock valued at $3,112,000 after purchasing an additional 61 shares during the period. 94.01% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Rothschild Redb upgraded shares of Waters to a “strong-buy” rating in a report on Wednesday, October 8th. Wells Fargo & Company dropped their target price on shares of Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a report on Tuesday, August 5th. Wall Street Zen lowered Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Jefferies Financial Group set a $385.00 price objective on Waters and gave the stock a “buy” rating in a research note on Monday, August 4th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $375.54.

Waters Trading Down 1.0%

Shares of WAT opened at $346.02 on Tuesday. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $20.60 billion, a price-to-earnings ratio of 31.20, a P/E/G ratio of 3.19 and a beta of 1.04. The stock’s 50-day moving average price is $317.68 and its 200 day moving average price is $324.75.

Waters (NYSE:WAT) last released its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The business had revenue of $608.55 million for the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. As a group, research analysts predict that Waters Corporation will post 12.86 earnings per share for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.